Kuros Biosciences AG (SWX:KURN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
28.40
+3.08 (12.16%)
Jun 26, 2025, 5:31 PM CET
140.68%
Market Cap 1.09B
Revenue (ttm) 75.56M
Net Income (ttm) -4.29M
Shares Out 38.37M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 544,532
Average Volume 179,254
Open 25.00
Previous Close 25.32
Day's Range 25.00 - 28.42
52-Week Range 10.74 - 32.00
Beta 0.69
RSI 62.85
Earnings Date Aug 14, 2025

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2016
Employees 122
Stock Exchange SIX Swiss Exchange
Ticker Symbol KURN
Full Company Profile

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.

Financial Statements

News

There is no news available yet.